Dynamic Healthcare M&A Database

Acquiring Party	Eli Lilly and Company (NYSE: LLY), a biopharmaceutical company developing treatments for depression, schizophrenia, ADHD, diabetes and osteoporosis among other conditions.
Transferring Party	ICOS Corporation (NASDAQ: ICOS), a biotechnology company (the maker of Cialis, erectile dysfunction drug).
Sector	Biopharmaceuticals
Date	December 19, 2006
Analysis Cialis to generate about $1b in '06 and has about a 26% US market share. Active ingredient may also treat swelling of the prostate known as BPH, or benign prostatic hyperplasia, and have application in treating sustained high blood pressure to the heart known as pulmonary arterial hypertension. Deal value -- $2.3b.
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.

Dynamic Healthcare M&A Database - 4Q06